Are you sure?

Gedeon Richter sees changes in executive board

Gábor Orbán, director of corporate strategy at Hungarian drugmaker Gedeon Richter, has been appointed by the Board of Directors as its general deputy CEO, according to an extraordinary announcement on the website of the Budapest Stock Exchange today. He will fill his role from January 1, 2017.

(Photo: LaMography/Moni Lazar)

The announcement adds that Chairman of the Board William de Gelsey intends to resign from his position from January 1, 2017, while leaving unaffected his status as a member of the board. 

In acknowledgement of his significant commitment and contribution to the company, the Board of Directors has decided to grant de Gelsey the title of “Lifetime Honorary Chairman of Gedeon Richter Plc.,” the announcement adds.

At a meeting on December 5, 2016, the Board of Directors elected its member, Erik Bogsch, CEO of the firm since 1992, as the new Chairman of the Board of Directors, with effect from January 1, 2017, the announcement says.